What did UBS change in the PEN analyst rating on Feb 26, 2026?

UBS **maintained Neutral** on Penumbra (PEN) on February 26, 2026, and kept a **$374** price target after reviewing Q4 results and adjusted EBITDA figures.

How should investors interpret a Neutral PEN analyst rating?

A Neutral PEN analyst rating signals limited near-term upside versus current price. It suggests monitoring execution and catalysts rather than initiating large new positions immediately.

Did the UBS note affect PEN share price or valuation metrics?

The UBS note coincided with a **-0.22%** intraday move (about **-$0.74**) and reiterated valuation context, including a P/E near **82.2** and market cap of **$13,413,408,766**.

Where can I find the UBS report and coverage cited in this article?

We referenced the UBS note published via StreetInsider and summarized by Investing.com. See the StreetInsider report [source](https://www.streetinsider.com/Analyst+Comments/UBS+Reiterates+Neutral+Rating+on+Penumbra+%28PEN%29+Following+Q4+Results/26066738.html) and Investing.com coverage [source](

Analyst Ratings

UBS Maintains Neutral on Penumbra (PEN) Feb 26, 2026

ByDanny Kontos February 27, 2026February 27, 2026

UBS maintained a Neutral rating on Penumbra, Inc. (PEN) on February 26, 2026, reiterating a $374 price target after the company’s fourth-quarter report. The PEN analyst rating from UBS followed stronger-than-expected adjusted EBITDA, but the firm kept its cautious stance given valuation metrics. We review the UBS call, the price target, short-term market reaction, and what the rating means for investors using Meyka AI-powered market analysis.